| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.46 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |